| Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening GL Lin, KM Wilson, M Ceribelli, BZ Stanton, PJ Woo, S Kreimer, EY Qin, ... Science translational medicine 11 (519), eaaw0064, 2019 | 172 | 2019 |
| Histone variant and cell context determine H3K27M reprogramming of the enhancer landscape and oncogenic state S Nagaraja, MA Quezada, SM Gillespie, M Arzt, JJ Lennon, PJ Woo, ... Molecular cell 76 (6), 965-980. e12, 2019 | 142 | 2019 |
| The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location I Liu, L Jiang, ER Samuelsson, S Marco Salas, A Beck, OA Hack, D Jeong, ... Nature Genetics 54 (12), 1881-1894, 2022 | 87 | 2022 |
| BAF complex maintains glioma stem cells in pediatric H3K27M glioma E Panditharatna, JG Marques, T Wang, MC Trissal, I Liu, L Jiang, A Beck, ... Cancer discovery 12 (12), 2880-2905, 2022 | 30 | 2022 |
| GABAergic neuron-to-glioma synapses in diffuse midline gliomas T Barron, B Yalçın, A Mochizuki, E Cantor, K Shamardani, D Tlais, ... bioRxiv, 2022.11. 08.515720, 2022 | 15 | 2022 |
| A light-gated transcriptional recorder for detecting cell-cell contacts KF Cho, SM Gillespie, NA Kalogriopoulos, MA Quezada, M Jacko, ... Elife 11, e70881, 2022 | 6 | 2022 |
| Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas M Bredel, L Espinosa, H Kim, DM Scholtens, JP McElroy, R Rajbhandari, ... Cell Reports Medicine 4 (6), 2023 | 2 | 2023 |
| GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant I Liu, GAV Cruzeiro, L Bjerke, RF Rogers, Y Grabovska, A Beck, A Mackay, ... Cancer Cell 42 (9), 1528-1548. e17, 2024 | | 2024 |
